Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

Oncogene
J A VranaS Grant

Abstract

Determinants of differentiation and apoptosis in myelomonocytic leukemia cells (U937) exposed to the novel hybrid polar compound SAHA (suberoylanilide hydroxamic acid) have been examined. In contrast to hexamethylenbisacetamide (HMBA), SAHA-related maturation was limited and accompanied by marked cytoxicity. SAHA-mediated apoptosis occurred within the G0G1 and S phase populations, and was associated with decreased mitochondrial membrane potential, caspase-3 activation, PARP degradation, hypophosphorylation/cleavage of pRB, and down-regulation of c-Myc, c-Myb, and B-Myb. Enforced expression of Bcl-2 or Bcl-XL inhibited SAHA-induced apoptosis, but only modestly potentiated differentiation. While SAHA induced the cyclin-dependent kinase inhibitor p21CIP1, antisense ablation of this CDKI increased, rather than decreased, SAHA-related lethality. In contrast, conditional expression of wild-type p53 failed to modify SAHA actions, but markedly potentiated HMBA-induced apoptosis. Finally, SAHA modestly increased expression/activation of the stress-activated protein kinase (SAPK/JNK); moreover, SAHA-related lethality was partially attenuated by a dominant-negative c-Jun mutant protein (TAM67). SAHA did not stimulate mitogen-activated pro...Continue Reading

References

May 15, 1976·International Journal of Cancer. Journal International Du Cancer·C Sundström, K Nilsson
Sep 1, 1976·Acta paediatrica Scandinavica·S WillnerC G Bergstrand
Mar 1, 1990·Clinical and Experimental Immunology·S J MartinT G Cotter
Nov 24, 1995·Science·Z XiaM E Greenberg
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Mar 1, 1997·Bone Marrow Transplantation·N HosoyaY Yazaki
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Y ArcherR A Hodin
Oct 31, 1998·Brain Research. Molecular Brain Research·A SalminenT Suuronen

❮ Previous
Next ❯

Citations

Apr 30, 2002·International Journal of Cancer. Journal International Du Cancer·Astrid A RuefliRicky W Johnstone
May 28, 2013·Apoptosis : an International Journal on Programmed Cell Death·Di WangXiaodan Yu
Oct 13, 2009·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Chunrui LiWenli Liu
Oct 2, 2001·Pharmacology & Therapeutics·M LeszczynieckaP B Fisher
Aug 16, 2001·Trends in Endocrinology and Metabolism : TEM·O H KrämerT Heinzel
Dec 4, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Clare Henderson, Claudio Brancolini
Aug 7, 2003·Current Opinion in Pharmacology·Paul A MarksVictoria M Richon
Sep 9, 2011·Molecular Pharmaceutics·Robert W RobeySusan E Bates
Apr 5, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuanqing WuImad Shureiqi
Jun 14, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Iva B Zovkic, J David Sweatt
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Jul 18, 2002·Nature Reviews. Drug Discovery·Ricky W Johnstone
Aug 13, 2008·Stem Cells and Development·Giovanni Di BernardoUmberto Galderisi
Aug 31, 2006·Anti-cancer Drugs·Amalia MilanoFrancesco Caponigro
Feb 17, 2006·Genes & Development·Oliver H KrämerThorsten Heinzel
Nov 20, 2012·Biochemistry. Biokhimii︠a︡·A A Vartanian
Feb 15, 2011·Journal of Biomedicine & Biotechnology·Riccardo MasettiAndrea Pession
Jan 3, 2014·The Journal of Clinical Investigation·Alison C West, Ricky W Johnstone
Feb 13, 2014·Journal of Photochemistry and Photobiology. B, Biology·Jane J SungTom C Karagiannis
Jun 20, 2014·ACS Medicinal Chemistry Letters·Fei ChenFa-Jun Nan
Jan 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·C-Y GuiP A Marks
Mar 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Melissa J PeartRicky W Johnstone
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Flavio LeoniPaolo Mascagni
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Jun 6, 2014·Cellular and Molecular Life Sciences : CMLS·Jing Zhang, Qing Zhong
Aug 21, 2014·Oxidative Medicine and Cellular Longevity·Barbora BrodskáAleš Holoubek
Dec 4, 2003·Expert Opinion on Therapeutic Targets·Thea Kalebic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.